CancerNetwork® spoke with Vivek Subbiah, MD, during the virtual American Association for Cancer Research Annual Meeting 2021 to discuss the most important data to come out of the meeting regarding therapy for tumors harboring KRAS mutations.
Vivek Subbiah, MD
Advertisement
Articles by Vivek Subbiah, MD
Advertisement
Latest Updated Articles
Vivek Subbiah, MD, on Data from AACR on Resistance Mechanisms to KRAS InhibitorsPublished: April 17th 2021 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
3
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
4
Unraveling the Complexities of Proximal-Type Epithelioid Sarcoma of the Vulva
5
